From cutting-edge research on Alzheimer’s disease to an innovative effort to include environmental justice and community engagement in climate and sustainability science research and education, University of California, Irvine scholars,…
Read More
News
UCI MIND researchers, Christian Salazar, PhD, MPH, and Maria Corona, PhD, have been awarded a UCI ICTS 2023 Campus-Community Researcher Incubator Award for their project, “Improving Knowledge and Awareness of…
Read More
Results were presented on Monday from the first-of-its kind Anti-Amyloid treatment in Asymptomatic Alzheimer’s (A4) Study. The A4 was a more than 10-year project to conduct one of the first…
Read More
The post UCI HD-CARE: Sounds of the Bayou appeared first on UCI MIND.
Read More
Results were presented on Monday for TRAILBLAZER-ALZ-2, a registration trial of the monoclonal antibody donanemab, which was previously announced as positive. The data were highly convincing that donanemab has a…
Read More
MNT spoke with Dr. Karen D. Lincoln, a professor in the Department of Environmental and Occupational Health at the University of California, Irvine. She noted that while some evidence suggests…
Read More
The post Support Groups with Cleo Dougherty appeared first on UCI MIND.
Read More
The post A December to Remember Gala appeared first on UCI MIND.
Read More
The post 34th Annual Southern California Alzheimer’s Disease Research Conference appeared first on UCI MIND.
Read More
July 6, 2023—Today, the US Food and Drug Administration granted full approval to the drug lecanemab (brand name Leqembi®), a monoclonal antibody that has been demonstrated to lower levels of…
Read More
On June 9, The US Food and Drug Administration convened members of the updated Peripheral and Central Nervous System Drugs Advisory Committee to review the available data for lecanemab, the monoclonal…
Read More
UCI MIND Director, Dr. Joshua Grill, named one of this year’s OC50 (50 people shaping the future of healthcare in Orange County) in the Orange County Business Journal. Read the…
Read More
Masashi Kitazawa, Associate Professor of Environmental and Occupational Health, and his team found exposure to traffic-related air pollution led to memory loss and cognitive decline and triggered neurological pathways associated…
Read More
May 12, 2023–Brexpiprazole has now been approved by the FDA for the treatment of agitation in Alzheimer’s dementia. Agitated behaviors are common in those with moderate or advanced Alzheimer’s dementia…
Read More
May 3, 2023–Eli Lilly and company announced today (https://investor.lilly.com/news-releases/news-release-details/lillys-donanemab-significantly-slowed-cognitive-and-functional) the positive topline results from their Phase 3 clinical trial of donanemab, a monoclonal antibody that rapidly lowers beta amyloid levels…
Read More
New number crunching from the Alzheimer’s Orange County estimates that the number of folks enduring this sort of heartbreak has essentially doubled since 2014 in the O.C. That’s a startling…
Read More
On Monday, April 17th, 2023, the trainee led Research and Education in Memory Impairments and Neurological Disorders (REMIND) held its 14th annual Emerging Scientists Symposium. The event is designed to help early career…
Read More
Dr. Frank LaFerla, Dean of the School of Biological Sciences and UCI MIND faculty member speaks at local educational event for the Alzheimer’s Foundation of America. Read about the event…
Read More